These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 29164413

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
    Schmocker RK, Wright MJ, Ding D, Javed AA, Cameron JL, Lafaro K, Burns WR, He J, Wolfgang CL, Burkhart RA.
    J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
    [Abstract] [Full Text] [Related]

  • 5. Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors.
    Untch BR, Bonner KP, Roggin KK, Reidy-Lagunes D, Klimstra DS, Schattner MA, Fong Y, Allen PJ, D'Angelica MI, DeMatteo RP, Jarnagin WR, Kingham TP, Tang LH.
    J Gastrointest Surg; 2014 Mar; 18(3):457-62; discussion 462-3. PubMed ID: 24448999
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endoscopic treatment of sporadic small duodenal and ampullary neuroendocrine tumors.
    Gincul R, Ponchon T, Napoleon B, Scoazec JY, Guillaud O, Saurin JC, Ciocirlan M, Lepilliez V, Pioche M, Lefort C, Adham M, Pialat J, Chayvialle JA, Walter T.
    Endoscopy; 2016 Nov; 48(11):979-986. PubMed ID: 27494453
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Surgical management of advanced pancreatic neuroendocrine tumors: short-term and long-term results from an international multi-institutional study.
    Birnbaum DJ, Turrini O, Vigano L, Russolillo N, Autret A, Moutardier V, Capussotti L, Le Treut YP, Delpero JR, Hardwigsen J.
    Ann Surg Oncol; 2015 Mar; 22(3):1000-7. PubMed ID: 25190116
    [Abstract] [Full Text] [Related]

  • 11. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
    Sperti C, Gruppo M, Blandamura S, Valmasoni M, Pozza G, Passuello N, Beltrame V, Moletta L.
    World J Gastroenterol; 2017 Jun 28; 23(24):4399-4406. PubMed ID: 28706422
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The role of lymph node ratio in recurrence after curative surgery for pancreatic endocrine tumours.
    Ricci C, Casadei R, Taffurelli G, Buscemi S, D'Ambra M, Monari F, Santini D, Campana D, Tomassetti P, Minni F.
    Pancreatology; 2013 Jun 28; 13(6):589-93. PubMed ID: 24280574
    [Abstract] [Full Text] [Related]

  • 16. Factors influencing recurrence after curative resection for ampulla of Vater carcinoma.
    Park JS, Yoon DS, Kim KS, Choi JS, Lee WJ, Chi HS, Kim BR.
    J Surg Oncol; 2007 Mar 15; 95(4):286-90. PubMed ID: 17326125
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors.
    Conlon KC, Klimstra DS, Brennan MF.
    Ann Surg; 1996 Mar 15; 223(3):273-9. PubMed ID: 8604907
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.